<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02677233</url>
  </required_header>
  <id_info>
    <org_study_id>vid-20</org_study_id>
    <nct_id>NCT02677233</nct_id>
  </id_info>
  <brief_title>Association Between Vitamin D Deficiency and Preeclampsia: A Case Control Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams Maternity Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams Maternity Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To find out if lower levels of vitamin D is more prevalent in preeclamptic women&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>vitamin D level in preeclamptic and non preeclamptic women</measure>
    <time_frame>six months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">90</enrollment>
  <condition>Pre-Eclampsia</condition>
  <arm_group>
    <arm_group_label>preeclamptic group</arm_group_label>
    <description>Blood pressure: greater than or equal to 140 mmHg systolic or greater than or equal to 90 mmHg diastolic on two occasions at least 4 hours apart after 20 weeks of gestation (Roberts et al., 2013).&#xD;
Proteinuria: protein/creatinine ratio greater than or equal to 0.3&#xD;
In the absence of proteinuria, a new-onset hypertension with new onset of the following:&#xD;
thrombocytopenia: platelet count less than 100.000/microliter&#xD;
renal insufficiency: serum creatinine greater than 1.1 mg/dl&#xD;
impaired liver function: elevated concentration of liver transaminases&#xD;
pulmonary edema&#xD;
cerebral or visual symptoms&#xD;
Severe right upper quadrant or epigastric pain unresponsive to medication.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non preeclamptic group</arm_group_label>
    <description>All are normotensive with blood pressure &lt;140/90 with no proteinuria.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This study will be carried out on 90 pregnant women recruited at pre labour room at Ain&#xD;
        Shams University Maternity Hospital. They will be divided into preeclamptic group and non&#xD;
        preeclamptic group, 45 cases in each one&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Parity: primigravida.&#xD;
&#xD;
          -  Age: 18 - 35 years.&#xD;
&#xD;
          -  Singleton pregnancy.&#xD;
&#xD;
          -  Gestational age: 36-40 weeks.&#xD;
&#xD;
          -  No past history of any medical disorder and with no other medical complications during&#xD;
             pregnancy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women with preexisting medical conditions like rheumatoid arthritis, thyroid, hepatic&#xD;
             or renal failure, metabolic bone disease, diabetes mellitus, malabsorption and lupus.&#xD;
&#xD;
          -  History of intake of medications influencing bone, vitamin D or calcium metabolism&#xD;
             e.g. antiepileptic, theophylline, antitubercular drugs in the last 6 months.&#xD;
&#xD;
          -  Women with multiple pregnancy.&#xD;
&#xD;
          -  Women with congenital fetal malformation.&#xD;
&#xD;
          -  Women with known thrombophilia&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>February 5, 2016</study_first_submitted>
  <study_first_submitted_qc>February 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2016</study_first_posted>
  <last_update_submitted>February 5, 2016</last_update_submitted>
  <last_update_submitted_qc>February 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams Maternity Hospital</investigator_affiliation>
    <investigator_full_name>Mohamed Salah sayed</investigator_full_name>
    <investigator_title>mohamed salah</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eclampsia</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

